ArticleHaematologica2019

Ruxolitinib in combination with prednisone and nilotinib exhibit synergistic effects in human cells lines and primary cells from myeloproliferative neoplasms.

Alicia Arenas Cortés et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.